At the time of the general election, several U.S states voted on marijuana legalization of some degree. Fast forward to the present, there are thirty-one states that have legalized the use of medicinal marijuana and nine, as well as the District of Columbia, that have gone a step further and legalized adult-use recreational marijuana as well.

Apart from the increase in social acceptance of pot, the indisputable financials of the industry are highly attractive. Last year, cannabis businesses generated over $1.5 billion just in Colorado, according to Colorado.gov. United States sales of medical and recreational marijuana are forecast to reach $22 billion by 2022, according to the 2018 edition of the Marijuana Business Factbook. As more states push to lift the prohibition on pot, it makes many question whether we will see legalization on a federal level in the future.

Recently we have seen many marijuana stocks such as Tilray (TLRY), Pyxus (PYX) and Cronos Group (CRON) rally on comments made by Constellation Brands’ (STZ) COO Bill Newlands and Citron Research. As investors continue to place bullish bets on the industry, here are four marijuana stocks to consider adding to your portfolio.

Canadian-based Integrated Cannabis develops, manufactures, and distributes botanically-based consumable products domestically and internationally. The company offers hemp-based CBD nutraceutical infused products under the X-SPRAYS brand and a THC-infused spray product. The company has a distribution agreement with Empower Clinics’ 15 locations throughout the U.S and completed a letter of agreement for collaboration on X-SPRAYS products with Canadian-licensed producer GTEC Holdings Ltd. (GTEC) (GGTTF) for the Canadian markets.

This morning, the company announced a retail-focused collaboration with New Age Farm, Inc. (NF) (NWGFF), to deliver CBD education and innovative CBD products to the Colorado market this fall. The companies will be retailing their CBD products through pop-up stores in Denver as well as educating the public about the benefits and uses of CBD.

Aurora Cannabis is vertically integrated and horizontally diversified from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, wholesale and retail distribution, and more. Aurora has seven facilities with production licenses and five with sales license, with supply agreements with several Canadian provinces.

The company announced yesterday the filing of an application to list its common shares on the New York Stock Exchange (NYSE). Aurora anticipates that, subject to receipt of all required approvals, trading in its common shares on the NYSE will begin before the end of October 2018.

This news followed Aurora announcing results for Q4 and 2018 Fiscal Year, with highlights including: top line revenue increasing 223%, gross margin on medical cannabis up 28%, and an active registered patient increase of 164%.

Trulieve Cannabis Corp (TCNNF) (TRUL.C)

Truelieve, which recently listed its shares on the Canadian Securities Exchange, cultivates, manufactures and distributes 90 cannabis-based products throughout 17 dispensaries across the state of Florida. Trulieve US is the first and largest fully-licensed medical marijuana company in the state and its revenue has increased from $15.2 million in the first quarter to $23.3 million in the second quarter of this year.

Truelieve is the latest new listing on the CSE, following a RTO with Schyan Exploration Inc., a reporting issuer in the Province of Ontario. Kim Rivers, CEO, stated, “Trulieve US was built with a patients-first mentality by focusing on improving access to medical cannabis while producing the highest quality products in the industry. Achieving this important milestone of a public listing enhances our ability to expand and serve more patients while allowing investors to participate in our growth.”

Aphria Inc. (APHQF) (APH)

Canadian-based Aphria cultivates and retails clean and pure pharmaceutical-grade cannabis with operations in ten countries across five continents. Iin connection with Drug Free Kids Canada announced today that they have entered into a Charter Agreement focused on increasing educational awareness of the potential harms of cannabis for children and underage youth and the safe and responsible use of cannabis by adults.

Aphria and Drug Free Kids are united by their shared values of keeping cannabis out of the hands of children and youth and raising awareness though effective educational campaigns. The Agreement is expected to produce new market research and cannabis health and safety campaigns, with a focus on protecting children and youth.

Shares of Aphria rallied during afternoon trading on Wednesday a report stated that the Marlboro cigarette maker is in talks to buy a stake in the Canadian marijuana company. Despite this, Aphria refuted this speculation stating that there is no agreement, understanding or arrangement in place with a potential investor at this time.